STOCK PURCHASE AGREEMENT STOCK PURCHASE AGREEMENTStock Purchase Agreement • March 15th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Stock Purchase Agreement (“Agreement”) is entered into as of March 14, 2018 (the “Execution Date”), by and between Ionis Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 2855 Gazelle Court, Carlsbad, California (“Ionis”), and Akcea Therapeutics, Inc., a Delaware corporation, having its principal place of business at 55 Cambridge Parkway, Suite 100, Cambridge, Massachusetts (“Akcea”). Akcea and Ionis each may be referred to herein individually as a “Party”, or collectively as the “Parties”.
STOCKHOLDER VOTING AGREEMENTStockholder Voting Agreement • March 15th, 2018 • Akcea Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Stockholder Voting Agreement (this “Agreement”) is made and entered into as of March 14, 2018, by and among Akcea Therapeutics, Inc. a Delaware corporation (the “Company”), having its principal place of business at 55 Cambridge Parkway, Suite 100, Cambridge, MA 02142, and Novartis Pharma AG, a company organized under the laws of Switzerland (the “Stockholder”), having its principal place of business at Lichtstrasse 35, 4002 Basel, Switzerland. The Company and Stockholder each may be referred to herein individually as a “Party”, or collectively as the “Parties”.
